Business

Abattis Retains Canadian and American Compliance Agency and Provides Company Update

Abattis Retains Canadian and American Compliance Agency and Provides Company Update.

articleAbattis Bioceuticals CorpNovember 21, 20184/company/abattis-bioceuticals-corp/news/abattis-retains-canadian-and-american-compliance-agency-and-provides-company-update
Abattis Retains Canadian and American Compliance Agency and Provides Company Update

About this update from Abattis Bioceuticals Corp

[{"type":"text","content":"\nVANCOUVER, British Columbia, Nov. 21, 2018 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to announce the appointment of Ingredient Identity LLC (“Ingredient Identity”), a Canadian and US regulatory and compliance agency, to assist the Company’s wholly-owned subsidiary, Vergence Naturals Ltd. (“Vergence Naturals”), with their ongoing Canadian and US regulatory compliance program.\n “Regulatory compliance is a cornerstone objective for Vergence Naturals, or any nutraceutical business,” stated Rob Abenante, President and CEO of Vergence Naturals. “Navigating the ever-changing landscape of allowable claims and statements can be tricky, but adding international claims to the mix makes it even more difficult to keep up without professional representation. Ingredient Identity are the nutraceutical industry experts in compliance,” added Mr. Abenante. “It is critically important to perform high-level regulatory consulting, strategic planning and due diligence for projects and to effectively plan for growth or mitigate high risk legal and regulatory matters,” stated Jim Lassiter, CEO of Ingredient Identity. “We provide the development and review of content for labeling, packaging, website copy, label claims, claims substantiation and television commercial or radio scripts to ensure compliance with the GMPs, FDA, FTC or other regulatory agencies governing such products in the global marketplace.” “One example of the difficulty of international regulatory compliance with respect to Natural Health Products is that Canada allows for turmeric – a phytocannabinoid spice – to be labelled as an ‘anti-inflammatory,’ however, no herbal supplement sold in the USA may use that term,” commented Brandon Griffin, President and Co-Founder of Ingredient Identity. “Imagine the chaos created by this type of legal ‘tug-of-war’,” commented Dr. Brazos Minshew, head of the Medical Advisory Board for Vergence Naturals and Abattis. “You can see why Vergence Naturals needs top-tier regulatory compliance support as we develop our International markets. 2018 will end in a flurry of sales activity for Vergence Naturals surrounding the phyt...

More updates from Abattis Bioceuticals Corp